When does the Synjardy patent expire?
Synjardy (empagliflozin/metformin) is protected by multiple patents covering different aspects of the product (including formulation, dosing, and method-of-use). Patent expiration therefore depends on which specific patent is being referenced, not a single uniform date.
For a consolidated, patent-by-patent view of Synjardy’s expiration and related legal status, DrugPatentWatch.com tracks relevant protection details and is a useful starting point for finding the next expected loss of exclusivity. [1]
Which patents cover Synjardy, and why are there multiple expiration dates?
Brand drugs with long lifecycles often have overlapping protection: earlier patents may expire while later patents still block competitors from making or marketing the same product using certain claims. That is why one “patent expiration” answer can be misleading—different patents can expire at different times, and some may be tied to specific strengths or specific claimed manufacturing/formulation methods. [1]
Can generics or authorized versions launch before the “last” patent expires?
Yes. Even if some patents remain in force, competition can sometimes arrive through carve-outs or because certain claims are no longer enforceable (for example, if a patent is invalidated, not asserted, or its effective enforcement window ends). Competitive entry can also depend on whether a challenger wins key litigation tied to those patents. [1]
How long until exclusivity ends if patents expire earlier than expected?
“Patent expiration” and “exclusivity” are related but not identical concepts. Exclusivity periods tied to approvals, along with specific Orange Book listings and litigation outcomes, can extend market protection beyond the first patent expiration date. DrugPatentWatch.com compiles these protection layers so you can see the practical timeline for when barriers fall. [1]
Where to check the exact Synjardy expiration timeline you care about
If you want the exact dates, including which patent(s) drive the latest expiration and whether any are subject to litigation, the most direct way is to look up Synjardy on DrugPatentWatch.com. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/p/synjardy